Metabolism and Excretion of 8-O-Acetylharpagide in Rats and Identification of Its Potential Anti-Breast Cancer Active Metabolites
As a prodrug, 8-O-acetylharpagide is metabolized to M5, which may subsequently exert an anti-breast cancer effect through downregulation of the AKT/NF-κB/MMP9 signaling axis. This study provides a theoretical basis for the clinical application of <i>Ajuga decumbens</i> in breast cancer therapy.
Authors
- Binyu Wen (ORCID: https://orcid.org/0000-0002-7549-1508)
- Junfeng Gao
- Sijia Su (ORCID: https://orcid.org/0009-0001-5682-3175)
- Xinyu Zhao (ORCID: https://orcid.org/0000-0002-3607-9000)
- Xu Tang (ORCID: https://orcid.org/0000-0002-9096-2961)
- Jingna Zhou (ORCID: https://orcid.org/0000-0003-0839-6452)
Institutions
- Beijing University of Chinese Medicine (CN)
Publication Details
- Journal
- Drug Design Development and Therapy
- Published
- 2025-04-01
- DOI
- https://doi.org/10.2147/dddt.s487898
- Primary Topic
- Eicosanoids and Hypertension Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 0.00